Article
Treatment Individualization in Colorectal Cancer
25 Aug 2015
Abstract excerpt
Colorectal cancer has been characterized as a genetically heterogeneous disease, with a large diversity in molecular pathogenesis resulting in differential responses to therapy. However, the currently available validated biomarkers KRAS, BRAF, and microsatellite instability do not sufficiently cover this extensive heterogeneity and are therefore not suitable to successfully guide personalized treatment. Recent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
